Background: Cardiovascular complications are major causes of morbidity and mortality following non-cardiac thoracic operations. Recent studies have demonstrated that elevation of N-Terminal Pro-B-type natriuretic peptide (NT-proBNP) levels can predict cardiac complications following non-cardiac major surgery as well as cardiac surgery. However, there is little information on the correlation between lung resection surgery and NT-proBNP levels. We evaluated the role of NT-proBNP as a potential marker for the risk stratification of cardiac complications following lung resection surgery. Material and Methods: Prospectively collected data of 98 patients, who underwent elective lung resection from August 2007 to February 2008, were analyzed. Postoperative adverse cardiac events were categorized as myocardial injury, ECG evidence of ischemia or arrhythmia, heart failure, or cardiac death. Results: Postoperative cardiac complications were documented in 9 patients (9/98, 9.2%): Atrial fibrillation in 3, ECG-evidenced ischemia in 2 and heart failure in 4. Preoperative median NT-proBNP levels was significantly higher in patients who developed postoperative cardiac complications than in the rest (200.2 ng/L versus 45.0 ng/L, p=0.009). NT-proBNP levels predicted adverse cardiac events with an area under the receiver operating characteristic curve of 0.76 [95% confidence interval (CI) 0.545∼0.988, p=0.01]. A preoperative NT-proBNP value of 160 ng/L was found to be the best cut-off value for detecting postoperative cardiac complication with a positive predictive value of 0.857 and a negative predictive value of 0.978. Other factors related to cardiac complications by univariate analysis were a higher American Society of Anesthesiologists grade, a higher NYHA functional class and a history of hypertension. In multivariate analysis, however, high preoperative NT-proBNP level (＞160 ng/L) only remained significant. Conclusion: An elevated preoperative NT-proBNP level is identified as an independent predictor of cardiac complications following lung resection surgery.
INTRODUCTION
Cardiovascular complications are major causes of morbidity and mortality following non-cardiac thoracic operations [1] . In order to improve risk stratification and predictability of potential postoperative complications, various tools, such as revised
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− 45 − cardiac risk index (RCRI) or American College of Cardiology/American Heart Association clinical risk factors, have been developed. These tools, however, cannot entirely replace a physician's judgment for individual patients, particularly because of the complexity of these diagnostic tools and the lack of evidentiary support for their usefulness [2] .
Therefore, simple and reliable method for identifying high-risk patients is necessary. It would allow a more targeted and more cost-effective application of prophylactic interventions. It would also enable us to detect postoperative cardiac complications earlier through vigilant surveillance over selected high-risk patients.
Cardiac natriuretic peptides including brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) have recently emerged as potentially useful biomarkers in the diagnosis and prognostic stratification of heart failure patients as well as patients in other clinical settings such as liver cirrhosis or chronic renal failure [3, 4] . More recently, it has been reported that these biomarkers are elevated in patients who experience perioperative cardiac complications following major cardiac and non-cardiac surgery [5] [6] [7] . However, there is little information on the correlation between lung resection surgery and NT-proBNP levels.
We evaluated the role of NT-proBNP as a potential marker for the risk stratification of cardiac complications following lung resection surgery.
MATERIAL AND METHODS

1) Study sample
One hundred one consecutive patients, who underwent elective lung resection surgery at our institute from August 2007 to February 2008, were enrolled in this prospective study. Among them, three patients were excluded due to newly developed arrhythmia during anesthesia or significant hypotension related to perioperative bleeding because the objective of this study was to observe the net effect of pulmonary resection on the development of cardiac complications.
Thus, 98 patients constituted the study cohort. Twenty-six patients had a history of hypertension and 6 of them had been taking beta-blocker. Five patients out of seven patients who had a history of coronary artery occlusive disease had received a percutaneous coronary artery intervention (PCI) or coronary artery bypass graft (CABG). All patients underwent elective lung resection surgery and had been free from major acute clinical events for at least two months before surgery.
Patients were assessed prior to surgery by an attending anesthesiologist for American Society of Anesthesiologists (ASA) score. The study protocol was approved by the local Institutional Review Board.
2) Data collection
Preoperative data collection encompassed patient demographic data, medical and surgical histories, preoperative medications, 12-lead electrocardiography (ECG), pulmonary function tests, and the data on renal and hepatic function.
Preoperative blood samples were also obtained to measure serum NT-proBNP level. The Revised Cardiac Risk Index (RCRI) was calculated from preoperative variables [8] . All patients remained under continuous ECG monitoring for at least 24 hours following surgery and underwent daily clinical cardiologic evaluations before discharge. All data was collected prospectively.
3) Postoperative cardiac events
The occurrence of cardiac-related death or cardiac complications requiring treatment (myocardial injury, ECG evidence of ischemia or arrhythmia, or heart failure) before discharge was evaluated. Acute postoperative myocardial injury was defined as the evidence of myocardial cell necrosis (Troponin T ＞0.1 mg/L). ECG evidence of ischemia was defined as the development of T-wave inversion of greater than 2 mm, and ST segment deviation of greater than 2 mm in at least two contiguous chest leads or greater than 1 mm in at least two contiguous limb leads. Arrhythmia was defined as a new sustained abnormal cardiac rhythm. All ECGs were analyzed by a cardiologist. Heart failure was defined as an occurrence of symptoms of congestive heart failure (orthopnea or dyspnea on exertions, venous distention, cardiomegaly, ankle edema, etc.) without the evidence of pneumonia.
4) Serum NT-proBNP assays
To measure the serum NT-proBNP levels, blood samples were obtained 12 hours before and after the operation. Before − 46 − the preoperative blood sample, patients were asked to lie quietly in the supine position to eliminate any potential effects of posture and exercise on serum NT-proBNP levels.
NT-proBNP was assayed by a semiautomated analyzer (Elecsys-1010, Roche Diagnostics, Germany) using an electrochemiluminescence immunoassay kit (Elecsys NT-proBNP Test, Roche Diagnostics, Mannheim, Germany).
5) Statistical analysis
Categorical data are presented as absolute values and percentage. Continuous variables are presented as the mean and standard deviation. Fisher's exact test was used to test differences between two independent categorical data.
Differences between two independent groups of continuous data were evaluated using Mann-Whitney U-test. To establish a NT-proBNP cut-off value with appropriate sensitivity and specificity, receiver operating characteristic (ROC) curves were plotted and the area under the curve was estimated. 
RESULTS
There were 60 male and 38 female patients, and their mean age was 61.1±12.0 years. Twenty seven patients (23.5%) suffered from postoperative complications. Eight patients had pulmonary complications such as pneumonia, acute lung injury or bronchopleural fistula, and one patient suffered from chylothorax. Prolonged air leakage (air leakage ＞5 days) occurred in 8 patients. Nine patients (9.2%) experienced cardiac complications following lung resection surgery. Atrial fibrillation occurred in 3 patients, ischemic change requiring vasodilator therapy in 2 patients, and heart failure in 3 patients including one patient with simultaneous pneumonia.
One patient had simultaneous atrial fibrillation and heart failure.
All cardiac events occurred within a week after the operation. ECG changes were identified in 9 patients (5 with T-wave or ST segment abnormalities and 4 with new onset atrial fibrillation). All patients with atrial fibrillation were treated with antiarrhythmic agent. Among 5 patients with T wave or ST segment abnormalities, two were treated with vasodilator immediately after the operation. All of these five patients' ECGs recovered to their preoperative state within 7 days. Acute myocardial injury did not occur in any patient.
Postoperative heart failure requiring inotropic agents occurred in 4 patients. All of them suffered from oliguria, leg edema and dyspnea without the evidence of pneumonia on a chest X-ray. Notably, ejection fractions determined with echocardiography decreased over 10% and ejection fractions were below 40% in 2 patients.
The relationship between preoperative and postoperative NT-proBNP levels and postoperative cardiac complications is demonstrated in Table 1 .
In patients with cardiac complications, both preoperative and postoperative NT-proBNP median values were significantly higher than in patients not experiencing cardiac complications ( Table 1 (Table 2) .
DISCUSSION
In this study, preoperative serum NT-proBNP was indicated as an independent predictor for cardiac complications follow-
NT-proBNP as a Predictor of Cardiac Complications
− 47 − CAD=Coronary artery disease; CABG=Coronary artery bypass graft; PCI=Percutaneous coronary intervention; RCRI=Revised Cardiac Risk; Index=NYHA, New York heart association; ASA=American society of anesthesiologists; LVEF=Left ventricular ejection fraction; FEV1=Forced expiratory ventilation in 1 second; VATS=Video assisted thoracoscopic surgery. Cardiac complications occur frequently after lung resection surgery. Atrial fibrillation is the most common cardiovascular complications after thoracic surgery, with a reported incidence of 8% to 20% after lobectomy and up to 40% after pneumonectomy [8, 9] . These events contribute significantly to morbidity, mortality and the increased cost of medical care.
Hence, a proactive approach for identifying patients with a higher risk for these complications is necessary.
Various tools have been developed to improve risk stratification and predictability for postoperative complications.
The most widely used risk assessment tool for predicting major cardiac complications after non cardiac surgery is the revised cardiac risk index (RCRI) [2] . The six independent risk Chang Young Lee, et al In our study, a high RCRI score (RCRI≥3) was not associated with postoperative cardiac complications ( Table 2 ).
Many surgeons utilize various preoperative imaging studies for cardiac function (including i.e. echocardiography, magnetic resonance imaging, and radionuclide studies) to evaluate left ventricular (LV) function [10] [11] [12] [13] . It is generally agreed that depressed LV function is associated with a higher risk of postoperative cardiac complications, but it remains debatable whether these tests provide additional information to routine clinical evaluation [14] . Halm et al. [10] reported that an LV ejection fraction of less than 40% was associated with postoperative cardiac complications, particularly heart failure.
However, our study demonstrated that the LV ejection fraction did not correlate with the risk of postoperative cardiac complications after lung resection surgery (Table 2) .
It has been suggested that NT-proBNP levels could be a useful markers of left ventricular dysfunction in both sympto- Further studies are necessary to support our observation, and to clarify the relationship between NT-proBNP levels and existing methods of risk stratification.
